Mounjaro Side Effects in Women: Periods, the Pill, Hair and Iron
In this article
- Do women get more side effects on Mounjaro than men?
- Does Mounjaro affect your periods?
- Does the pill still work on Mounjaro?
- Does Mounjaro affect HRT?
- Hair loss in women on Mounjaro
- Iron: the deficiency most likely to find you
- Nausea, constipation and the rest
- Are there long-term side effects of Mounjaro in women?
- What we don't know
- Frequently asked questions
Most of the side effects women report on Mounjaro are side effects of losing weight quickly, not of the medicine. Periods change because body fat and the hormones it makes are changing. Hair sheds because fast weight loss shocks the hair cycle. Iron runs low because a smaller diet and monthly periods pull in opposite directions. The exceptions are the ones that come from a slower stomach: anything you swallow, including the contraceptive pill and oral HRT, may be absorbed differently, and the product information says so. None of this is a reason to panic, and one thing on the list, bleeding after the menopause, is always a GP appointment regardless of what you are taking.
- Periods: heavier, lighter, earlier or back after years; weight loss changes the hormones that time them
- The pill: the product information advises a barrier method for four weeks after starting and after each dose increase
- Hair: shedding three to four months in, usually temporary, linked to pace of loss, protein and iron
- Iron: women of reproductive age are already the group most likely to be low; a smaller diet makes it likelier
- HRT and the menopause: absorption of oral HRT may change; any bleeding after the menopause needs a GP
Sources checked on 29 October 2026.
Do women get more side effects on Mounjaro than men?
In the main weight-management trial, 67.5% of the 2,539 participants were women, and gut effects, led by nausea and diarrhoea, were the most common side effects across the board.1, 9 In an analysis of 25,212 adverse event reports to the US regulator, women reported more injection-site reactions and men more gut effects, and the authors note that reporting biases shape such databases as much as any true difference.2 There is no good evidence that the medicine itself works differently in women; what differs is what the weight loss does to a female body. This page joins those questions up; each has its own article. It is one chapter of our guide to living well on Mounjaro.
Does Mounjaro affect your periods?
Not directly, as far as anyone has shown. Indirectly, yes, and often. Body fat produces oestrogen and influences the hormones that control ovulation, so losing a lot of it changes the cycle. Women who had irregular or absent periods, including many with polycystic ovary syndrome, frequently find them returning or becoming regular as weight falls, which is a well-documented effect of weight loss by any method and the reason GLP-1 medicines are being studied for fertility.3 Others find periods heavier, lighter or earlier for a few months while things settle. A returning cycle also means returning fertility, which matters for the next section.
Two things are not part of that normal picture. Bleeding between periods that persists beyond a cycle or two, and any bleeding at all after the menopause, need a GP appointment. Do not accept a forum explanation for post-menopausal bleeding.
Does the pill still work on Mounjaro?
This is the one effect on the list that is about the medicine rather than the weight. Mounjaro slows the stomach, and the UK product information for tirzepatide advises women using oral contraceptives to add a barrier method, or switch to a non-oral method, for four weeks after starting and for four weeks after each dose increase, because absorption of the pill may be reduced during those windows.9 In the single-dose study of tirzepatide, peak levels of the pill's hormones fell by 55% to 66% and overall exposure by about a fifth, a change the product information calls not clinically relevant in women of normal weight while noting limited information in women with obesity; an exenatide study found a smaller, transient effect; the concern is strongest when the stomach is slowest.4, 5, 9 Since fertility often returns as weight falls, follow the advice to the letter. If a non-oral method, such as an implant, injection, coil or patch, suits you, it sidesteps the question entirely. Pregnancy and contraception on Mounjaro covers what to do if you become pregnant while taking it. Anyone planning berberine after the injections reads berberine for women first.
Does Mounjaro affect HRT?
By the same logic, possibly, if your HRT is taken by mouth. Oral oestrogen and progestogen are absorbed through the gut, and a slower stomach may change how much reaches you and when; one published case report describes hot flushes and mood changes returning in a woman on oral oestrogen during semaglutide dose increases, easing when the increases were slowed, and a 2026 review sets out why an effect on oral progestogens is plausible but untested.6, 10 Patches, gels and sprays bypass the gut and are not affected. If your hot flushes or sleep get worse in the weeks after starting or increasing Mounjaro, raise it with whoever prescribes your HRT; it may be a timing or route question with a simple answer.
Hair loss in women on Mounjaro
Shedding three to four months after fast weight loss is common and usually temporary. The mechanism is telogen effluvium, the hair cycle's response to a physical shock, which is why it also follows childbirth, illness and crash diets, and why the shedding lags the trigger by months.7 It is reported more often in women,7 who are also the group most often short of iron.8 It grows back as weight stabilises and intake is adequate. Does Mounjaro cause hair loss has the full timeline and the nutrients that matter.
Iron: the deficiency most likely to find you
Women of childbearing age are among the groups most at risk of iron deficiency before any medicine is involved.8 Add months of eating less, with red meat, beans and leafy greens among the first foods to drop, and the risk rises. Low iron produces exactly the symptoms people blame on Mounjaro: tiredness, feeling cold, hair shedding, breathlessness on stairs.8 The answer is a blood test for ferritin and a full blood count first, then iron if the result shows you are short, because too much iron causes its own problems. Why am I so tired on Mounjaro lists what to ask your GP to check.
Nausea, constipation and the rest
The digestive side effects are the same for everyone and have their own pages: feeling sick, constipation and diarrhoea, sulphur burps and heartburn. One pattern women describe more often is the week-before-a-period water retention masking weight loss on the scale, which is covered in why has my weight loss stalled. Can Mounjaro cause thrush or a UTI? No trial links the medicine to either. The plausible route is fluid: days of nausea, vomiting or diarrhoea mean drinking less, and the NHS lists not drinking enough fluids among the things that raise UTI risk.11 What to do is unchanged: a pharmacist (women aged 16 to 64 who are not pregnant or breastfeeding) or GP for a urinary infection,11 an antifungal from a pharmacist for thrush you have had diagnosed before, and why UTIs keep coming back or what causes thrush if either repeats.
Are there long-term side effects of Mounjaro in women?
The main weight-management trial ran for 72 weeks and did not report effects specific to women beyond those above.1 Longer-term data is still being collected. The long-term questions that matter most for women are nutritional: protecting muscle and bone through a long period of eating less, and keeping iron, vitamin D and protein adequate. Those are covered across the guide.
What we don't know
- Whether tirzepatide itself changes oral HRT or contraceptive absorption beyond the first weeks. A tirzepatide study found changes in pill hormone levels; longer-term evidence is from related medicines and case reports.5
- True sex differences in side-effect rates. Reporting differences make them hard to measure.
- Effects on the menopause transition itself. Not studied.
Frequently asked questions
What does Mounjaro do to female hormones?
Nothing directly that has been shown. Losing body fat changes oestrogen and the hormones that time ovulation, which is why periods often change and fertility can return.3
Can Mounjaro make the contraceptive pill fail?
Absorption of the pill may be reduced in the four weeks after starting and after each dose increase; the product information advises a barrier or non-oral method in those windows.4
Is Mounjaro hair loss permanent in women?
Usually not. It is a temporary shedding that follows fast weight loss by three to four months and regrows as weight settles, provided protein and iron are adequate.7, 12
Should women on Mounjaro take iron?
Only if a blood test shows they need it. Women who have periods are the group most often low, so the test is worth asking for if you are tired, cold or shedding hair.
Sources
- Jastreboff AM, et al. Tirzepatide once weekly for the treatment of obesity. New England Journal of Medicine, 2022. Randomised trial (SURMOUNT-1), 2,539 adults, 72 weeks; manufacturer-funded. PubMed 35658024.
- Chen H, et al. Post-marketing safety monitoring of tirzepatide: a pharmacovigilance study based on the FAERS database. Expert Opinion on Drug Safety, 2025. Pharmacovigilance analysis of 25,212 reports, 2022 to 2023; funding not stated on PubMed. PubMed 40037695.
- Becker AS, et al. GLP-1 receptor agonists and fertility: what is known so far? JBRA Assisted Reproduction, 2026. Narrative review, 47 papers. PubMed 42441883.
- Kothare PA, et al. Effect of exenatide on the pharmacokinetics of a combination oral contraceptive in healthy women: an open-label, randomised, crossover trial. BMC Clinical Pharmacology, 2012. Randomised crossover trial, 32 healthy women; authors employed by the manufacturer. PubMed 22429273.
- Min JS, et al. A comprehensive review on the pharmacokinetics and drug-drug interactions of approved GLP-1 receptor agonists and a dual GIP/GLP-1 receptor agonist. Drug Design, Development and Therapy, 2025. Narrative review; no conflicts declared, funding not stated on PubMed. PubMed 40330819.
- Viana DPDC, et al. Tirzepatide and oral progestogens: a hypothesis-generating review of a biologically plausible pharmacokinetic interaction. Maturitas, 2026. Narrative review, literature to February 2026; funding not stated on PubMed. PubMed 42721915.
- Gupta AK, et al. GLP-1 therapies and hair loss: a systematic review of current evidence and implications for counseling. Science Progress, 2026. Systematic review, 24 studies; one author reports trial grants from pharmaceutical companies including the manufacturer. PubMed 41998799.
- Lopez A, et al. Iron deficiency anaemia. Lancet, 2016. Clinical seminar. PubMed 26314490.
- Tirzepatide Summary of Product Characteristics, sections 4.5 (oral contraceptives), 4.8 (hair loss 4.9% against 1.0%) and 5.1 (SURMOUNT-1: 2,539 adults, 67.5% women), electronic medicines compendium, date of revision of the text 29 August 2026. medicines.org.uk.
- Parker AE. Worsening vasomotor symptoms in the setting of estradiol and semaglutide: a case report. Menopause, 2025. Single case report; no conflicts reported. PubMed 40729307.
- NHS. Urinary tract infections (UTIs). Page last reviewed 11 July 2025. nhs.uk.
- Malkud S. Telogen effluvium: a review. Journal of Clinical and Diagnostic Research, 2015. Narrative review; funding not stated on PubMed. PubMed 26500992.
Spotted something out of date? Email support@wellgard.co.uk with the page address and the sentence.
This article is general information, not medical advice. Mounjaro is a prescription medicine: follow the product information and your prescriber's advice on contraception, and see your GP about any bleeding after the menopause or between periods.